|
Nov 3
|
Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting
|
|
Nov 3
|
Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak™ and Dagger™ Technologies at the Society for Immunotherapy of Cancer Annual Meeting
|
|
Nov 3
|
Allogene's (ALLO) Q3 Loss Narrower Than Expected, Sales Miss
|
|
Nov 2
|
Allogene Therapeutics Inc (ALLO) Reports Q3 2023 Financial Results
|
|
Nov 2
|
Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update
|
|
Nov 2
|
Allogene Therapeutics Announces Poster Presentations at the 65th Annual Meeting of the American Society of Hematology
|
|
Aug 29
|
16 Most Shorted Stocks Right Now
|
|
May 25
|
Immutep (IMMP) Up on Initial Data From Lung Cancer Study
|
|
May 24
|
Icosavax (ICVX) Up on Positive VLP Vaccine Candidate Data
|
|
May 24
|
Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences
|
|
May 24
|
INOVIA's (INO) Rare Disease Drug Gets EC's Orphan Tag, Stock Up
|
|
May 22
|
We Think Allogene Therapeutics (NASDAQ:ALLO) Needs To Drive Business Growth Carefully
|
|
May 19
|
PDS Biotech (PDSB) Completes Enrollment for HPV Cancer Study
|
|
May 19
|
AbbVie's (ABBV) Rinvoq Gets FDA Nod to Treat Crohn's Disease
|
|
Mar 30
|
Allogene Therapeutics Publishes 2022 Annual Environmental, Social and Governance (ESG) Report
|